- By FYH News Team
[ad_1]
Puccini’s Madama Butterfly tells the tragic love story of a Japanese girl betrayed by her American naval officer husband. It is a production that at once showcases one of the most heart-wrenchingly beautiful arias in Italian opera and yet the worst stereotypes of Asian women. So how are modern opera companies handling these issues when it comes to developing new productions that won’t turn off audiences in 2022?
More opera companies are having open discussions about improved ways of staging new productions and the role ethnic stereotyping plays in upholding systemic racism. Asian opera artists say the acknowledgement of these issues is particularly important given the climate of increased anti-Asian racism.
But shows built on Orientalist themes continue to be staged with non-Asian artists costumed into Asian roles. Even following a year of consultation on how to respectfully portray Japanese culture, London’s Royal Opera House went ahead with a production of Madama Butterfly with a nearly all-non-Asian cast. Critics say the practice amounts to yellowface and devalues the experiences of opera singers of Asian descent.
In this episode of the Stream, we’ll look at why such practices still persist in modern opera productions and what’s being done about it.
Join the conversation:
TWITTER: https://twitter.com/AJStream
FACEBOOK: http://www.facebook.com/AJStream
Subscribe to our channel http://bit.ly/AJSubscribe
#aljazeeraenglish
#ajstream
#MadamaButterfly
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
- Jessica Wilson
- Jessica Wilson
- Victor Mejia

















